The Lancet Diabetes & Endocrinology is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constructive, positive change worldwide. The journal is the global leader for essential original research in diabetes and endocrinology and delivers expert review and candid commentary, providing a clear, independent perspective about the clinical advances and practice-changing research shaping these fields globally.
The Lancet Diabetes & Endocrinology publishes papers that reflect the rich variety of ongoing clinical research in these fields, in particular in the areas of diabetes, obesity, nutrition and metabolism, osteoporosis, adrenal disorders, bone metabolism, growth disorders, lipid disorders, neuroendocrinology, paediatric endocrinology, pituitary disorders, reproductive endocrinology, and thyroid disorders.
The Lancet Diabetes & Endocrinology (LDE)
is :
International, Peer-Reviewed, Open Access, Refereed,
Medicine, Endocrinology, Metabolism, Molecular Biology
,
Online
or
Print,
Monthly
Journal
UGC Approved, ISSN Approved: P-ISSN - 2213-8587, E-ISSN - 2213-8595, Established in - 2013, Impact Factor
True scholar network
